Invivyd

IVVDNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$171.638 M

$0.58 -8.10%

Close of 6 Nov 2026

As of 6 Nov 2026, Invivyd (IVVD) has a market capitalization of $171.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$53.4M

#2693 by revenue

Earnings

-$52.5M

Loss-making

Shares outstanding

294,758,746

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#97Inhibikase TherapeuticsIKT$201.6M
#98CompugenCGEN$183.0M
#99InvivydIVVD$171.6M
#100Innate PharmaIPHA$156.4M
#101Sutro BiopharmaSTRO$152.0M

What if Invivyd were worth as much as…

Open the what-if tool →

Gold $28.2T

$95,796.56

Per share 164,514× higher

Bitcoin $1.53T

$5,183.39

Per share 8,902× higher

Apple $5.02T

$17,016.57

Per share 29,223× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Invivyd are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.